CMP: $23

Obagi Medical Products, Inc. develops skin care pharmaceuticals. The Company develops prescription topical treatments for premature aging, photo-damage, hyper-pigmentation acne, and soft tissue deficits such as fine lines and wrinkles.

Obagi Medical Products is a $400 Million market cap company trading at a P/E of 25. Revenues have risen from $113 Millions to $121 Millions in the last 2 years. Profits have risen from less than $10 Millions to nearly $17 Millions in the last 2 years. Profit margins have surged from less than 9% to nearly 14% in the last 2 years. With no long term debt, it looks to be a great bet for long term investment.